BDBM791196 3-(3-chlorophenyl)-2-(3-{[(2S)-1-(ethenesulfonyl)pyrrolidin-2-yl]methoxy}pyridin-4-yl)-1H-pyrrolo[3,2-b]pyridine::US20260035365, Example 40

SMILES C=CS(=O)(=O)N1CCC[C@H]1COc1cnccc1-c1[nH]c2cccnc2c1-c1cccc(Cl)c1

InChI Key

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 791196   

TargetEpidermal growth factor receptor [1-770,'SVD',771-1210](Human)
Bayer Aktiengesellschaft; The Broad Institute, Inc.; Dana-Farber Cancer Institute, Inc.

US Patent
LigandChemical structure of BindingDB Monomer ID 791196BDBM791196(3-(3-chlorophenyl)-2-(3-{[(2S)-1-(ethenesulfonyl)p...)
Affinity DataIC50: 0.193nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

TargetEpidermal growth factor receptor [1-770,'NPG',771-1210](Human)
Bayer Aktiengesellschaft; The Broad Institute, Inc.; Dana-Farber Cancer Institute, Inc.

US Patent
LigandChemical structure of BindingDB Monomer ID 791196BDBM791196(3-(3-chlorophenyl)-2-(3-{[(2S)-1-(ethenesulfonyl)p...)
Affinity DataIC50: 0.290nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent